Core IM | Internal Medicine Podcast cover image

#189 Bisphosphonates and Fracture Prevention Trial: Beyond Journal Club with NEJM Group

Core IM | Internal Medicine Podcast

00:00

What changed with intravenous zoledronate (HORIZON)?

Discussion of the HORIZON trial showing yearly IV zoledronate reduced clinically significant vertebral fractures and had lasting effects.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app